Day: January 25, 2021

ROCHESTER, Mich., Jan. 25, 2021 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported preliminary unaudited results for its fourth quarter and full year ended December 31, 2020.For the fourth quarter, the company expects record revenue of approximately $16 million, up 117% versus the fourth quarter of 2019, along with positive GAAP net income. The record revenue was primarily driven by strong organic growth in messaging and patient engagement solutions.For the full year, the company expects record revenue of approximately $43 million, up 75% over 2019.“Our fourth quarter showed a strong finish to a great year of growth and market expansion, with this largely driven by life science companies increasingly using our nationwide...

PLANO, Texas., Jan. 25, 2021 (GLOBE NEWSWIRE) — In a release issued under the same headline on Thursday, January 21st, 2021 by INTRUSION Inc. (NASDAQ: INTZ), please note the Vice President of Sales, Tina Carnow, does not report to the Senior Vice President of Sales Engineering, Joe Head, as previously stated. The corrected release follows:INTRUSION Inc. (NASDAQ: INTZ), a leading provider of entity identification, high speed data mining, cybercrime and advanced persistent threat detection services, is expanding its sales and engineering teams to support the company’s continued growth.Joe Head, one of INTRUSION’s co-founders, has been named Senior Vice President of Sales Engineering. In this role, he will lead a team of engineers who will support the sales team’s efforts to help demonstrate the technology and value of INTRUSION’s...

VANCOUVER, British Columbia, Jan. 25, 2021 (GLOBE NEWSWIRE) — TELUS Corporation (TSX: T; NYSE: TU) announced today that its subsidiary, TELUS International (Cda) Inc. (TELUS International), has disclosed its preliminary and unaudited estimates of selected results for the three months and full year ended December 31, 2020. TELUS International has disclosed these preliminary results in connection with its previously announced initial public offering. The preliminary results are presented below.The following information reflects preliminary estimates with respect to such results based on currently available information, is not a comprehensive statement of TELUS International’s financial results and is subject to completion of its financial closing procedures.TELUS International’s financial closing procedures are not yet complete and,...

VANCOUVER, Colombie-Britannique, 25 janv. 2021 (GLOBE NEWSWIRE) — TELUS Corporation (TSX: T; NYSE: TU) a annoncé aujourd’hui que sa filiale, TELUS International (Cda) inc. (TELUS International), a divulgué des estimations provisoires et non vérifiées de certains résultats pour le trimestre et l’année s’étant terminés le 31 décembre 2020. TELUS International a divulgué ces résultats préliminaires en lien avec son premier appel public à l’épargne annoncé précédemment. Les résultats provisoires sont présentés ci-dessous.Les renseignements suivants sont des estimations provisoires des résultats selon l’information actuellement disponible, ne constituent pas une déclaration exhaustive des résultats financiers de TELUS International et sont sujets à changer suivant les procédures de fin d’année financière.L’année financière de TELUS International...

VANCOUVER, British Columbia, Jan. 25, 2021 (GLOBE NEWSWIRE) — TELUS International, a subsidiary of TELUS Corporation (TSX: T; NYSE: TU), today announced it has launched a roadshow for the initial public offering (IPO) of its subordinate voting shares.TELUS International is offering 33.33 million of its subordinate voting shares in the IPO, including 21.93 million from treasury and 11.40 million from TELUS Corporation (TELUS) and Baring Private Equity Asia, its selling shareholders. The underwriters will also have a 30-day option to purchase up to 5.0 million additional subordinate voting shares at the IPO price, less underwriting discounts and commissions. The IPO price is currently expected to be between US$23 and US$25 per share. TELUS International will list its subordinate voting shares on the New York Stock Exchange and Toronto...

VANCOUVER, Colombie-Britannique, 25 janv. 2021 (GLOBE NEWSWIRE) — TELUS International, une filiale de TELUS Corporation (TSX : T; NYSE : TU), a annoncé aujourd’hui qu’elle entreprenait une tournée de promotion pour son premier appel public à l’épargne visant l’émission d’actions à droit de vote subalterne.TELUS International offrira dans ce contexte 33,33 millions de ces actions, y compris 21,93 millions d’actions de trésorerie et 11,40 millions d’actions de TELUS Corporation (TELUS) et de Baring Private Equity Asia, les actionnaires vendeurs. Les preneurs fermes pourront aussi exercer une option dans les 30 jours suivant la clôture de l’émission pour acheter jusqu’à 5,0 millions d’actions à droit de vote subalterne supplémentaires au prix du premier appel public à l’épargne, moins les réductions de prise ferme et commissions. Le...

Stock Up Express (www.stockupexpress.com) Receives More Than 1,000,000 Annual Online Visitors, Consisting of a Diverse Group of Customers NEW YORK, NY, Jan. 25, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as an ongoing Pharmaceutical Development initiative, today announced that it has entered into a distribution agreement (the “Agreement”) with Stock Up Express, a division of a leading total services distributor that generates more than $3 Billion in annual sales.  Stock Up Express is based in Connecticut and is a leading web-based grocer and wholesaler...

Press releaseSynairgen plc(‘Synairgen’ or the ‘Company’)Synairgen announces inclusion of its inhaled interferon beta treatment in US NIH ACTIV-2 trial in COVID-19 outpatientsACTIV partnership is funded by “Operation Warp Speed”, led by the US Government’s Department of Health and Human Services and designed to speed up the development of the most promising treatments and vaccine candidates for COVID-19Southampton, UK – 25 January 2021: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, today announces a clinical trial agreement to include its inhaled interferon beta-1a treatment (SNG001) in the ACTIV-2/A5401 Phase II/III trial in patients with COVID-19 not yet requiring hospitalisation. The trial is sponsored by the US National Institute of Allergy and Infectious Diseases (NIAID), part of the US National...

Pressmeddelande 2021-01-25ArcAroma och Cerealiq metodutvecklingsarbete har resulterat i patentansökan för en ny unik innovation inom området havremjölk.Cerealiq företräds av en ägargrupp som har ett gediget förflutet inom den svenska havredryckesindustrin vilka sedan tidigare står bakom flera patenterade uppfinningar inom området. Den nya innovationen som utvecklats genom ett samarbete mellan ArcAroma och Cerealiq i utvecklingen av den nya generationens ”Clean label”. Dessa ”hälsosamma havredrycker” skapar genom en unik produktionsmetod klart förbättrade skumningsegenskaper för havremjölk. Denna egenskap är viktig vid framtagandet av olika kaffevarianter på världens kafféer.Världsmarknaden för havremjölk är i stark tillväxt. 2019 omsattes 360 millioner USD, prognosen för 2027 är 995 millioner USD.”Nu när marknaden för vegetabiliska livsmedel...